ONCOLYTICS BIOTECH INC

Oncolytics Biotech Inc.

Biotechnology Healthcare Calgary, AB, United States ONCY (NCM)

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has ONCOLYTICS BIOTECH INC had layoffs?
No layoff events have been recorded for ONCOLYTICS BIOTECH INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does ONCOLYTICS BIOTECH INC have?
ONCOLYTICS BIOTECH INC has approximately 28 employees.
What industry is ONCOLYTICS BIOTECH INC in?
ONCOLYTICS BIOTECH INC operates in the Biotechnology industry, within the Healthcare sector.
Is ONCOLYTICS BIOTECH INC a publicly traded company?
Yes, ONCOLYTICS BIOTECH INC is publicly traded under the ticker symbol ONCY on the NCM. The company has a market capitalization of approximately $0.10 billion.
Where is ONCOLYTICS BIOTECH INC headquartered?
ONCOLYTICS BIOTECH INC is headquartered in Calgary, AB, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.